Clinical Research Directory

Inclusion Criteria: 1. Male or female ≥18 years old 2. Clinical diagnosis of moderate scalp psoriasis assessed by Psoriasis Scalp Severity Index (PSSI, moderate = 3-10) 3. At least a score of 1 grade for each symptom erythema, induration and desquamation 4. Subject is willing and able to use Daxxin Psoriasis Shampoo as directed, comply with investigation instructions, and commit to all follow-up visits for the duration of the investigation, as judged by the Investigator 5. Subject agrees to refrain from using other treatments for scalp psoriasis during the clinical investigation 6. Subject is willing and able to provide written informed consent Exclusion Criteria: 1. Known allergy or sensitivity to any component of the device 2. Use of psoriasis shampoo 2 weeks prior to enrolment 3. Use of other psoriasis scalp treatment i.e., Betnovate that could affect the study result within 4 weeks prior to enrolment 4. Use of systemic and/or biological treatment for psoriasis 5. Subject has a history of psoriasis unresponsive to topical treatments 6. Subject is pregnant, lactating at time of enrolment, or is planning to become pregnant during the study 7. Subjects with any other condition that, as judged by the investigator, may make investigation procedures inappropriate 8. Subject with alcohol or drug abuse